{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "pd.set_option(\"display.max_columns\", 500)\n",
    "pd.set_option(\"display.width\", 1000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>component</th>\n",
       "      <th>regulator</th>\n",
       "      <th>date</th>\n",
       "      <th>condition</th>\n",
       "      <th>accelerated</th>\n",
       "      <th>withdrawn</th>\n",
       "      <th>first_in_class</th>\n",
       "      <th>note</th>\n",
       "      <th>context</th>\n",
       "      <th>stage_or_status</th>\n",
       "      <th>risk_stratification</th>\n",
       "      <th>demographics</th>\n",
       "      <th>prior_therapy</th>\n",
       "      <th>prior_therapy_negation</th>\n",
       "      <th>prior_therapy_setting</th>\n",
       "      <th>response_contingency</th>\n",
       "      <th>time_contingency</th>\n",
       "      <th>prior_biomarker</th>\n",
       "      <th>with</th>\n",
       "      <th>biomarker</th>\n",
       "      <th>biomarker_negation</th>\n",
       "      <th>study_yn</th>\n",
       "      <th>study</th>\n",
       "      <th>string</th>\n",
       "      <th>date_added.x</th>\n",
       "      <th>drug_CUI</th>\n",
       "      <th>drug_INN</th>\n",
       "      <th>investigational</th>\n",
       "      <th>main_class</th>\n",
       "      <th>class_type</th>\n",
       "      <th>CanMED_major_class</th>\n",
       "      <th>CanMED_major_class_CUI</th>\n",
       "      <th>CanMED_minor_class</th>\n",
       "      <th>CanMED_minor_class_CUI</th>\n",
       "      <th>date_added.y</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Abarelix</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2003-11-25</td>\n",
       "      <td>Prostate cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Symptomatic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>men</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>Koch et al. 2003</td>\n",
       "      <td>2003-11-25: Approved for palliative treatment ...</td>\n",
       "      <td>2022-09-05</td>\n",
       "      <td>3652</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>GnRH antagonist</td>\n",
       "      <td>mechanistic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-08-29</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Abciximab</td>\n",
       "      <td>FDA</td>\n",
       "      <td>1994-12-22</td>\n",
       "      <td>NONE</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>True</td>\n",
       "      <td>No linked condition</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1994-12-22: Initial approval (label not availa...</td>\n",
       "      <td>2022-09-05</td>\n",
       "      <td>3</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>Anti-GPIIb-IIIa antibody</td>\n",
       "      <td>mechanistic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2019-05-27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2017-09-28</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Metastatic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>women and men</td>\n",
       "      <td>Antiestrogen AND Chemotherapy</td>\n",
       "      <td>False</td>\n",
       "      <td>Metastatic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>HR+ and HER2-</td>\n",
       "      <td>FALSE AND TRUE</td>\n",
       "      <td>True</td>\n",
       "      <td>MONARCH 1</td>\n",
       "      <td>2017-09-28: FDA approved as monotherapy for wo...</td>\n",
       "      <td>2022-09-05</td>\n",
       "      <td>4</td>\n",
       "      <td>abemaciclib</td>\n",
       "      <td>False</td>\n",
       "      <td>CDK4/6 inhibitor</td>\n",
       "      <td>mechanistic</td>\n",
       "      <td>CDK inhibitor</td>\n",
       "      <td>44963</td>\n",
       "      <td>CDK4 inhibitor|CDK6 inhibitor</td>\n",
       "      <td>32998|32999</td>\n",
       "      <td>2019-05-27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2017-09-28</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Advanced OR Metastatic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>women</td>\n",
       "      <td>Antiestrogen</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Fulvestrant</td>\n",
       "      <td>HR+ and HER2-</td>\n",
       "      <td>FALSE AND TRUE</td>\n",
       "      <td>True</td>\n",
       "      <td>MONARCH 2</td>\n",
       "      <td>2017-09-28: FDA approved in combination with &lt;...</td>\n",
       "      <td>2022-09-05</td>\n",
       "      <td>4</td>\n",
       "      <td>abemaciclib</td>\n",
       "      <td>False</td>\n",
       "      <td>CDK4/6 inhibitor</td>\n",
       "      <td>mechanistic</td>\n",
       "      <td>CDK inhibitor</td>\n",
       "      <td>44963</td>\n",
       "      <td>CDK4 inhibitor|CDK6 inhibitor</td>\n",
       "      <td>32998|32999</td>\n",
       "      <td>2019-05-27</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2018-02-26</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>False</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Advanced OR Metastatic</td>\n",
       "      <td>NaN</td>\n",
       "      <td>postmenopausal women</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Aromatase inhibitor</td>\n",
       "      <td>HR+ and HER2-</td>\n",
       "      <td>FALSE AND TRUE</td>\n",
       "      <td>True</td>\n",
       "      <td>MONARCH 3</td>\n",
       "      <td>2018-02-26: FDA approved in combination with a...</td>\n",
       "      <td>2022-09-05</td>\n",
       "      <td>4</td>\n",
       "      <td>abemaciclib</td>\n",
       "      <td>False</td>\n",
       "      <td>CDK4/6 inhibitor</td>\n",
       "      <td>mechanistic</td>\n",
       "      <td>CDK inhibitor</td>\n",
       "      <td>44963</td>\n",
       "      <td>CDK4 inhibitor|CDK6 inhibitor</td>\n",
       "      <td>32998|32999</td>\n",
       "      <td>2019-05-27</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     component regulator        date        condition accelerated withdrawn first_in_class                 note context         stage_or_status risk_stratification          demographics                  prior_therapy prior_therapy_negation prior_therapy_setting response_contingency time_contingency prior_biomarker                 with      biomarker biomarker_negation study_yn             study                                             string date_added.x  drug_CUI     drug_INN  investigational                main_class   class_type CanMED_major_class CanMED_major_class_CUI             CanMED_minor_class CanMED_minor_class_CUI date_added.y\n",
       "0     Abarelix       FDA  2003-11-25  Prostate cancer       False     False           True                  NaN     NaN             Symptomatic                 NaN                   men                            NaN                    NaN                   NaN                  NaN              NaN             NaN                  NaN            NaN                NaN     True  Koch et al. 2003  2003-11-25: Approved for palliative treatment ...   2022-09-05      3652          NaN            False           GnRH antagonist  mechanistic                NaN                    NaN                            NaN                    NaN   2019-08-29\n",
       "1    Abciximab       FDA  1994-12-22             NONE       False     False           True  No linked condition     NaN                     NaN                 NaN                   NaN                            NaN                    NaN                   NaN                  NaN              NaN             NaN                  NaN            NaN                NaN      NaN               NaN  1994-12-22: Initial approval (label not availa...   2022-09-05         3          NaN            False  Anti-GPIIb-IIIa antibody  mechanistic                NaN                    NaN                            NaN                    NaN   2019-05-27\n",
       "2  Abemaciclib       FDA  2017-09-28    Breast cancer       False     False          False                  NaN     NaN              Metastatic                 NaN         women and men  Antiestrogen AND Chemotherapy                  False            Metastatic                  NaN              NaN             NaN                  NaN  HR+ and HER2-     FALSE AND TRUE     True         MONARCH 1  2017-09-28: FDA approved as monotherapy for wo...   2022-09-05         4  abemaciclib            False          CDK4/6 inhibitor  mechanistic      CDK inhibitor                  44963  CDK4 inhibitor|CDK6 inhibitor            32998|32999   2019-05-27\n",
       "3  Abemaciclib       FDA  2017-09-28    Breast cancer       False     False          False                  NaN     NaN  Advanced OR Metastatic                 NaN                 women                   Antiestrogen                  False                   NaN                  NaN              NaN             NaN          Fulvestrant  HR+ and HER2-     FALSE AND TRUE     True         MONARCH 2  2017-09-28: FDA approved in combination with <...   2022-09-05         4  abemaciclib            False          CDK4/6 inhibitor  mechanistic      CDK inhibitor                  44963  CDK4 inhibitor|CDK6 inhibitor            32998|32999   2019-05-27\n",
       "4  Abemaciclib       FDA  2018-02-26    Breast cancer       False     False          False                  NaN     NaN  Advanced OR Metastatic                 NaN  postmenopausal women                            NaN                    NaN                   NaN                  NaN              NaN             NaN  Aromatase inhibitor  HR+ and HER2-     FALSE AND TRUE     True         MONARCH 3  2018-02-26: FDA approved in combination with a...   2022-09-05         4  abemaciclib            False          CDK4/6 inhibitor  mechanistic      CDK inhibitor                  44963  CDK4 inhibitor|CDK6 inhibitor            32998|32999   2019-05-27"
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "hemonc_data = pd.read_csv(\"hemonc_joined.csv\")\n",
    "hemonc_data.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Drug approval dates\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>component</th>\n",
       "      <th>regulator</th>\n",
       "      <th>date</th>\n",
       "      <th>condition</th>\n",
       "      <th>withdrawn</th>\n",
       "      <th>drug_CUI</th>\n",
       "      <th>with</th>\n",
       "      <th>string</th>\n",
       "      <th>approval_year</th>\n",
       "      <th>withdrawal_year</th>\n",
       "      <th>active_years</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Abarelix</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2003-11-25</td>\n",
       "      <td>Prostate cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>3652</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2003-11-25: Approved for palliative treatment ...</td>\n",
       "      <td>2003.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2003, 2004, 2005, 2006, 2007, 2008, 2009, 201...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2017-09-28</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>4</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2017-09-28: FDA approved as monotherapy for wo...</td>\n",
       "      <td>2017.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2017-09-28</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>4</td>\n",
       "      <td>Fulvestrant</td>\n",
       "      <td>2017-09-28: FDA approved in combination with &lt;...</td>\n",
       "      <td>2017.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2018-02-26</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>4</td>\n",
       "      <td>Aromatase inhibitor</td>\n",
       "      <td>2018-02-26: FDA approved in combination with a...</td>\n",
       "      <td>2018.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2018, 2019, 2020, 2021, 2022, 2023, 2024]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2021-10-12</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>4</td>\n",
       "      <td>Aromatase inhibitor OR Tamoxifen</td>\n",
       "      <td>2021-10-12: Approved with endocrine therapy (t...</td>\n",
       "      <td>2021.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2021, 2022, 2023, 2024]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "      component regulator       date        condition  withdrawn  drug_CUI                              with                                             string  approval_year  withdrawal_year                                       active_years\n",
       "0      Abarelix       FDA 2003-11-25  Prostate cancer      False      3652                               NaN  2003-11-25: Approved for palliative treatment ...         2003.0              NaN  [2003, 2004, 2005, 2006, 2007, 2008, 2009, 201...\n",
       "2   Abemaciclib       FDA 2017-09-28    Breast cancer      False         4                               NaN  2017-09-28: FDA approved as monotherapy for wo...         2017.0              NaN   [2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024]\n",
       "3   Abemaciclib       FDA 2017-09-28    Breast cancer      False         4                       Fulvestrant  2017-09-28: FDA approved in combination with <...         2017.0              NaN   [2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024]\n",
       "4   Abemaciclib       FDA 2018-02-26    Breast cancer      False         4               Aromatase inhibitor  2018-02-26: FDA approved in combination with a...         2018.0              NaN         [2018, 2019, 2020, 2021, 2022, 2023, 2024]\n",
       "11  Abemaciclib       FDA 2021-10-12    Breast cancer      False         4  Aromatase inhibitor OR Tamoxifen  2021-10-12: Approved with endocrine therapy (t...         2021.0              NaN                           [2021, 2022, 2023, 2024]"
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Cols of interest\n",
    "cols = [\n",
    "    \"component\",\n",
    "    \"regulator\",\n",
    "    \"date\",\n",
    "    \"condition\",\n",
    "    \"withdrawn\",\n",
    "    \"drug_CUI\",\n",
    "    \"with\",\n",
    "    \"string\",\n",
    "]\n",
    "approv_hem_data = hemonc_data[cols]\n",
    "\n",
    "# check for missing / null values in year and in condition\n",
    "approv_hem_data = approv_hem_data[approv_hem_data[\"condition\"] != \"NONE\"]\n",
    "approv_hem_data = approv_hem_data[approv_hem_data[\"regulator\"] == \"FDA\"]\n",
    "\n",
    "# Convert 'date' to datetime year month day and withdraw to boolean\n",
    "approv_hem_data[\"date\"] = pd.to_datetime(approv_hem_data[\"date\"], errors=\"coerce\")\n",
    "approv_hem_data[\"withdrawn\"] = approv_hem_data[\"withdrawn\"].astype(bool)\n",
    "\n",
    "# create a new column 'approval_year' and set it to the year of the date if withdrawn is false\n",
    "approv_hem_data[\"approval_year\"] = np.where(\n",
    "    ~approv_hem_data[\"withdrawn\"], approv_hem_data[\"date\"].dt.year, np.nan\n",
    ")\n",
    "\n",
    "# if withdrawn is true then create a new column 'withdrawn_year' and set it to the year of the date\n",
    "approv_hem_data[\"withdrawal_year\"] = np.where(\n",
    "    approv_hem_data[\"withdrawn\"], approv_hem_data[\"date\"].dt.year, np.nan\n",
    ")\n",
    "\n",
    "# Convert 'active_years' to a list of years\n",
    "approv_hem_data[\"active_years\"] = [\n",
    "    (\n",
    "        list(range(int(approval), int(withdrawal) + 1))\n",
    "        if not np.isnan(withdrawal) and not np.isnan(approval)\n",
    "        else list(range(int(approval), 2025)) if not np.isnan(approval) else np.nan\n",
    "    )\n",
    "    for approval, withdrawal in zip(\n",
    "        approv_hem_data[\"approval_year\"], approv_hem_data[\"withdrawal_year\"]\n",
    "    )\n",
    "]\n",
    "\n",
    "approv_hem_data.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>component</th>\n",
       "      <th>regulator</th>\n",
       "      <th>date</th>\n",
       "      <th>condition</th>\n",
       "      <th>withdrawn</th>\n",
       "      <th>drug_CUI</th>\n",
       "      <th>with</th>\n",
       "      <th>string</th>\n",
       "      <th>approval_year</th>\n",
       "      <th>withdrawal_year</th>\n",
       "      <th>active_years</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>551</th>\n",
       "      <td>Capivasertib</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2023-11-16</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>2</td>\n",
       "      <td>Fulvestrant</td>\n",
       "      <td>2023-11-16: Approved with fulvestrant for adul...</td>\n",
       "      <td>2023.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2023, 2024]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>552</th>\n",
       "      <td>Capivasertib</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2023-11-16</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>2</td>\n",
       "      <td>Fulvestrant</td>\n",
       "      <td>2023-11-16: Approved with fulvestrant for adul...</td>\n",
       "      <td>2023.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2023, 2024]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>Abiraterone</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2011-04-28</td>\n",
       "      <td>Prostate cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>6</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2011-04-28: &lt;a target=\"_blank\" rel=\"noreferrer...</td>\n",
       "      <td>2011.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2011, 2012, 2013, 2014, 2015, 2016, 2017, 201...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>Abiraterone</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2012-12-10</td>\n",
       "      <td>Prostate cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>6</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2012-12-10: &lt;a target=\"_blank\" rel=\"noreferrer...</td>\n",
       "      <td>2012.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2012, 2013, 2014, 2015, 2016, 2017, 2018, 201...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>Acalabrutinib</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2017-10-31</td>\n",
       "      <td>Mantle cell lymphoma</td>\n",
       "      <td>False</td>\n",
       "      <td>7</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2017-10-31: Granted accelerated approval for t...</td>\n",
       "      <td>2017.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2226</th>\n",
       "      <td>Pertuzumab and Trastuzumab hyaluronidase</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2020-06-29</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>111391</td>\n",
       "      <td>Chemotherapy</td>\n",
       "      <td>2020-06-29: Initial approval in combination wi...</td>\n",
       "      <td>2020.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2020, 2021, 2022, 2023, 2024]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2219</th>\n",
       "      <td>Pertuzumab and Trastuzumab hyaluronidase</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2020-06-29</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>111391</td>\n",
       "      <td>Docetaxel</td>\n",
       "      <td>2020-06-29: Initial approval in combination wi...</td>\n",
       "      <td>2020.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2020, 2021, 2022, 2023, 2024]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2220</th>\n",
       "      <td>Pertuzumab and Trastuzumab hyaluronidase</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2020-06-29</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>False</td>\n",
       "      <td>111391</td>\n",
       "      <td>Docetaxel</td>\n",
       "      <td>2020-06-29: Initial approval in combination wi...</td>\n",
       "      <td>2020.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2020, 2021, 2022, 2023, 2024]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1393</th>\n",
       "      <td>Iobenguane I 131</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2018-07-30</td>\n",
       "      <td>Paraganglioma</td>\n",
       "      <td>False</td>\n",
       "      <td>115124</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2018-07-30: Initial approval for the treatment...</td>\n",
       "      <td>2018.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2018, 2019, 2020, 2021, 2022, 2023, 2024]</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1394</th>\n",
       "      <td>Iobenguane I 131</td>\n",
       "      <td>FDA</td>\n",
       "      <td>2018-07-30</td>\n",
       "      <td>Pheochromocytoma</td>\n",
       "      <td>False</td>\n",
       "      <td>115124</td>\n",
       "      <td>NaN</td>\n",
       "      <td>2018-07-30: Initial approval for the treatment...</td>\n",
       "      <td>2018.0</td>\n",
       "      <td>NaN</td>\n",
       "      <td>[2018, 2019, 2020, 2021, 2022, 2023, 2024]</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>978 rows Ã— 11 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     component regulator       date             condition  withdrawn  drug_CUI          with                                             string  approval_year  withdrawal_year                                       active_years\n",
       "551                               Capivasertib       FDA 2023-11-16         Breast cancer      False         2   Fulvestrant  2023-11-16: Approved with fulvestrant for adul...         2023.0              NaN                                       [2023, 2024]\n",
       "552                               Capivasertib       FDA 2023-11-16         Breast cancer      False         2   Fulvestrant  2023-11-16: Approved with fulvestrant for adul...         2023.0              NaN                                       [2023, 2024]\n",
       "16                                 Abiraterone       FDA 2011-04-28       Prostate cancer      False         6           NaN  2011-04-28: <a target=\"_blank\" rel=\"noreferrer...         2011.0              NaN  [2011, 2012, 2013, 2014, 2015, 2016, 2017, 201...\n",
       "19                                 Abiraterone       FDA 2012-12-10       Prostate cancer      False         6           NaN  2012-12-10: <a target=\"_blank\" rel=\"noreferrer...         2012.0              NaN  [2012, 2013, 2014, 2015, 2016, 2017, 2018, 201...\n",
       "27                               Acalabrutinib       FDA 2017-10-31  Mantle cell lymphoma      False         7           NaN  2017-10-31: Granted accelerated approval for t...         2017.0              NaN   [2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024]\n",
       "...                                        ...       ...        ...                   ...        ...       ...           ...                                                ...            ...              ...                                                ...\n",
       "2226  Pertuzumab and Trastuzumab hyaluronidase       FDA 2020-06-29         Breast cancer      False    111391  Chemotherapy  2020-06-29: Initial approval in combination wi...         2020.0              NaN                     [2020, 2021, 2022, 2023, 2024]\n",
       "2219  Pertuzumab and Trastuzumab hyaluronidase       FDA 2020-06-29         Breast cancer      False    111391     Docetaxel  2020-06-29: Initial approval in combination wi...         2020.0              NaN                     [2020, 2021, 2022, 2023, 2024]\n",
       "2220  Pertuzumab and Trastuzumab hyaluronidase       FDA 2020-06-29         Breast cancer      False    111391     Docetaxel  2020-06-29: Initial approval in combination wi...         2020.0              NaN                     [2020, 2021, 2022, 2023, 2024]\n",
       "1393                          Iobenguane I 131       FDA 2018-07-30         Paraganglioma      False    115124           NaN  2018-07-30: Initial approval for the treatment...         2018.0              NaN         [2018, 2019, 2020, 2021, 2022, 2023, 2024]\n",
       "1394                          Iobenguane I 131       FDA 2018-07-30      Pheochromocytoma      False    115124           NaN  2018-07-30: Initial approval for the treatment...         2018.0              NaN         [2018, 2019, 2020, 2021, 2022, 2023, 2024]\n",
       "\n",
       "[978 rows x 11 columns]"
      ]
     },
     "execution_count": 76,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# confirm there is only one row for each drug + with combination\n",
    "approv_hem_data[\n",
    "    approv_hem_data.duplicated(subset=[\"drug_CUI\", \"with\"], keep=False)\n",
    "].sort_values(by=[\"drug_CUI\", \"with\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {},
   "outputs": [],
   "source": [
    "# check duplicate entries in drug approval for differences\n",
    "# some are due to combination therapy rows-> how want to handle active years for these?\n",
    "# need to go through string column to see differences -> ? in other metadata columns"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Trial Status dates\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['component', 'regulator', 'date', 'condition', 'accelerated', 'withdrawn', 'first_in_class', 'note', 'context', 'stage_or_status', 'risk_stratification', 'demographics', 'prior_therapy', 'prior_therapy_negation', 'prior_therapy_setting', 'response_contingency', 'time_contingency', 'prior_biomarker', 'with', 'biomarker', 'biomarker_negation', 'study_yn', 'study', 'string', 'date_added.x', 'drug_CUI', 'drug_INN', 'investigational', 'main_class', 'class_type', 'CanMED_major_class', 'CanMED_major_class_CUI', 'CanMED_minor_class', 'CanMED_minor_class_CUI', 'date_added.y'], dtype='object')"
      ]
     },
     "execution_count": 66,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "hemonc_data.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/06/cy8f7k7d5pb31b4b4fpr97z80000gn/T/ipykernel_20760/911262475.py:12: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
      "  trial_hem_data[\"trial_year\"] = trial_hem_data[\"string\"].str.extract(\"(\\d{4})\")\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>component</th>\n",
       "      <th>condition</th>\n",
       "      <th>study_yn</th>\n",
       "      <th>study</th>\n",
       "      <th>string</th>\n",
       "      <th>drug_CUI</th>\n",
       "      <th>trial_year</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Abarelix</td>\n",
       "      <td>Prostate cancer</td>\n",
       "      <td>True</td>\n",
       "      <td>Koch et al. 2003</td>\n",
       "      <td>2003-11-25: Approved for palliative treatment ...</td>\n",
       "      <td>3652</td>\n",
       "      <td>2003</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Abciximab</td>\n",
       "      <td>NONE</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1994-12-22: Initial approval (label not availa...</td>\n",
       "      <td>3</td>\n",
       "      <td>1994</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>True</td>\n",
       "      <td>MONARCH 1</td>\n",
       "      <td>2017-09-28: FDA approved as monotherapy for wo...</td>\n",
       "      <td>4</td>\n",
       "      <td>2017</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>True</td>\n",
       "      <td>MONARCH 2</td>\n",
       "      <td>2017-09-28: FDA approved in combination with &lt;...</td>\n",
       "      <td>4</td>\n",
       "      <td>2017</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Abemaciclib</td>\n",
       "      <td>Breast cancer</td>\n",
       "      <td>True</td>\n",
       "      <td>MONARCH 3</td>\n",
       "      <td>2018-02-26: FDA approved in combination with a...</td>\n",
       "      <td>4</td>\n",
       "      <td>2018</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "     component        condition study_yn             study                                             string  drug_CUI trial_year\n",
       "0     Abarelix  Prostate cancer     True  Koch et al. 2003  2003-11-25: Approved for palliative treatment ...      3652       2003\n",
       "1    Abciximab             NONE      NaN               NaN  1994-12-22: Initial approval (label not availa...         3       1994\n",
       "2  Abemaciclib    Breast cancer     True         MONARCH 1  2017-09-28: FDA approved as monotherapy for wo...         4       2017\n",
       "3  Abemaciclib    Breast cancer     True         MONARCH 2  2017-09-28: FDA approved in combination with <...         4       2017\n",
       "4  Abemaciclib    Breast cancer     True         MONARCH 3  2018-02-26: FDA approved in combination with a...         4       2018"
      ]
     },
     "execution_count": 71,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Cols of interest\n",
    "cols = [\n",
    "    \"component\",\n",
    "    \"condition\",\n",
    "    \"study_yn\",\n",
    "    \"study\",\n",
    "    \"string\",\n",
    "    \"drug_CUI\",\n",
    "]\n",
    "trial_hem_data = hemonc_data[cols]\n",
    "\n",
    "# Extract the year from the 'string' column\n",
    "trial_hem_data[\"trial_year\"] = trial_hem_data[\"string\"].str.extract(\"(\\d{4})\")\n",
    "\n",
    "# check for missing / null values in year and in condition\n",
    "trial_hem_data = trial_hem_data[trial_hem_data[\"condition\"] != \"nan\"]\n",
    "\n",
    "trial_hem_data.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "# check what is in string- why differences"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "nlp_3.9",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.19"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
